What is Timely by DrFirst?
Founded in 2000 and headquartered in Rockville, Maryland, DrFirst has established itself as a pioneer in healthcare technology solutions and consulting services. The company focuses on securely connecting individuals at every touchpoint of care to enhance patient outcomes. DrFirst develops unconventional solutions designed to break down information silos and address critical challenges in care collaboration, medication management, price transparency, and adherence within the healthcare ecosystem. Its commitment to innovation positions it as a key player in modernizing healthcare delivery.
How much funding has Timely by DrFirst raised?
Timely by DrFirst has raised a total of $142.5M across 7 funding rounds:
Debt
$10M
Multiple Rounds
$65.5M
Unspecified
$17M
Other Financing Round
$50M
Debt (2014): $10M with participation from Silicon Valley Bank
Private Equity (2015): $3.5M, investors not publicly disclosed
Debt (2015): $12M supported by SunTrust Bank
Private Equity (2015): $25M featuring Goldman Sachs
Private Equity (2015): $25M backed by Goldman Sachs
Unspecified (2019): $17M with participation from SunTrust Banks
Other Financing Round (2021): $50M led by Sixth Street
Key Investors in Timely by DrFirst
Sixth Street
Sixth Street is a global investment firm with significant assets under management, known for its investments in prominent companies. Their participation suggests a strategic alignment with DrFirst's growth objectives.
SunTrust Bank
SunTrust Bank, a diversified financial services provider, has been involved in DrFirst's funding rounds, indicating a role in supporting the company's debt financing and operational growth.
Goldman Sachs
Goldman Sachs, a leading global investment banking firm, has provided private equity backing to DrFirst, highlighting their confidence in the company's market potential and strategic direction.
What's next for Timely by DrFirst?
The substantial enterprise-level funding and recent strategic investment indicate that Timely by DrFirst is likely in a growth or scaling phase, aiming to expand its market reach and further develop its innovative healthcare technology solutions. This capital infusion will likely fuel strategic initiatives, including potential acquisitions, enhanced research and development, and broader market penetration. The company's focus on solving complex healthcare challenges suggests a continued emphasis on technological advancement and strategic partnerships to solidify its position in the evolving healthtech landscape.
See full Timely by DrFirst company page
